Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BrainBerry is a private UK digital health and medtech company developing personalized neurofeedback therapies for neurological and mental health conditions. Its offering combines serious games, a wearable brainwave-monitoring headset, and machine-learning software to support individualized assessment, monitoring, and treatment. The company has been described as operating in mental health, neuroscience, and healthcare technology rather than as a traditional drug-development biotech. BrainBerry was founded in 2015, originally under the name Cerebrum Matter, and remains active as BrainBerry Ltd. Based on available public information, its business appears focused on commercializing a digital therapeutic/neurotechnology platform rather than advancing a conventional pharmaceutical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BrainBerry.